Mechanism of Classical Prescriptions of Rhubarb Delaying Progression of Chronic Kidney Disease

TU Yue; SUN Wei; WAN Yi-gang; LIU Hong; YU Bing-yin

doi:10.11653/syfj2014050222

您当前的位置：

首页 >

文章列表页 >

Mechanism of Classical Prescriptions of Rhubarb Delaying Progression of Chronic Kidney Disease

更新时间：2024-01-04

- Mechanism of Classical Prescriptions of Rhubarb Delaying Progression of Chronic Kidney Disease
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 5, Pages: 222-228(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2014050222
  CLC：
- Published：2014
- 稿件说明：
移动端阅览
TU Yue, SUN Wei, WAN Yi-gang, et al. Mechanism of Classical Prescriptions of Rhubarb Delaying Progression of Chronic Kidney Disease[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(5): 222-228.
DOI：

TU Yue, SUN Wei, WAN Yi-gang, et al. Mechanism of Classical Prescriptions of Rhubarb Delaying Progression of Chronic Kidney Disease[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(5): 222-228. DOI： 10.11653/syfj2014050222.

摘要

对大黄类经方延缓慢性肾脏病（CKD）进展的机制进行了总结。通过对国内外文献的整理发现治疗CKD的大黄类经方包括：大黄附子汤、大黄甘草汤、大黄庶虫虫丸和温脾汤等。针对CKD的发病机制，从西医和中医两个角度进行了总结；并分别从临床疗效和药理机制两个方面入手，归纳了各个经方治疗CKD的研究进展；以及对这些经方的主要组成药物——大黄的研究进展进行了概述，在大黄类经方治疗CKD的药理机制研究方面，今后可以从经方的主要组成药物的关键组分入手，进行体内、外的机制研究，以期从更深层次、更全面地阐明大黄类经方治疗CKD的相关机制；在临床试验研究方面，应加以双盲、随机、对照为原则的大样本临床试验，选择严密的阳性药物对照，对病人进行病候的辨证，使中医药治疗CKD的临床试验研究更为规范、可靠、全面。为大黄类经方在CKD的临床试验研究和药理机制研究提供了文献梳理和理论指导。

Abstract

This paper summarized the research progress of rhubarb and its classical prescriptions in treating chronic kidney disease(CKD). These prescriptions include Dahuangfuzi dcoction

Dahuanggancao dcoction

Dahuangzhechong pill and Wenpi dcoction. The pathogenesis of CKD was introduced from the aspects of Western medicine and Chinese medcine. Moreover

the prescriptions in treating CKD were summarized from the aspects of clinical effect and pharmacological mechanism. In addition

the mechanisms of rhubarb

as the main component of these prescriptions

were elaborated. This article supplies reference arrangement and theoretical guidance for clinical and experimental researches.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction

Mechanism of Naoxintong Capsules Against Ischemia-reperfusion Injury in Rats via Inhibiting Pericyte Contraction Based on RHOA/ROCK1 Pathway

Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis

Multidimensional Analysis of Mechanisms of Nuciferine Against Cerebral Ischemia Based on Transcriptomic Data

Clinical Efficacy of Jinwei Pingchuan Decoction in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Phlegm-heat Obstruction in Lung Syndrome

Related Author

YANG Lele

LUO Danmei

CHEN Jiao

ZHANG Xiaobo

SONG Wei

ZHU Wenyu

ZHOU Xin

LI Xueping

Related Institution

Hospital of Chengdu University of Traditional Chinese Medicine （TCM）

Chengdu University of TCM

School of Chinese Materia Medica， Beijing University of Chinese Medicine

Liaoning University of Traditional Chinese Medicine（TCM）

Affiliated Hospital of Liaoning University of TCM

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰